Answers are grounded in this paper and cite their sources.
Further knowledge of the underlying CRC mechanisms and a comprehensive overview of current therapeutic opportunities can provide the basis for identifying pharmacological and biological barriers that render therapies ineffective and for identifying new potential biomarkers and therapeutic targets for advanced and aggressive CRC.
No takes yet. Share an insight, caveat, or question.
Tirendi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: